Odyssey-backed EAG invests in ABC Laboratories' biopharmaceutical analysis

EAG Inc., a scientific services company majority-owned by Odyssey Investment Partners LLC, announced an investment in ABC Laboratories. EAG acquired ABC, which provides biopharmaceutical analysis for drug companies, in July 2015.

18 May 2016•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles